Tennessee · 114th Regular Session (2025-2026) · Bill

HB 2246: Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68.

Enacted Last action May 26, 2026: Pub. Ch. 1016

Plain-language summary

HB 2246 is a bill introduced in the Tennessee House on February 2, 2026. According to its official title, it concerns: Health Care - As enacted, authorizes a physician to perform stem cell therapy or regenerative medicine therapy that is not approved by the United States food and drug administration if such therapy is used for a treatment or procedure that is within the scope of practice of the physician; makes related changes. - Amends TCA Title 63 and Title 68. Primary sponsor: Chris Hurt (Republican). Most recent recorded action (May 26, 2026): Pub. Ch. 1016.

Sponsors

Primary sponsor: Chris Hurt (Republican).